Jan 2014 update
Description
Acceleron Pharma Inc. is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of protein therapeutics for cancer and rare diseases. The Company’s research focuses on the biology of the Transforming Growth Factor-Beta (TGF-b) protein superfamily, a large and diverse group of molecules that are key regulators in the growth and repair of tissues throughout the human body. By coupling its discovery and development expertise, including its knowledge of the TGF-b superfamily, with its internal protein engineering and manufacturing capabilities, it has built a productive research and development platform that has generated clinical and preclinical protein therapeutic candidates with mechanisms of action.
Address
128 Sidney Street
CAMBRIDGE, MA 02139
United States
CAMBRIDGE, MA 02139
United States
Key stats and ratios
| Q3 (Sep '13) | 2012 | |
| Net profit margin | -433.56% | -213.60% |
| Operating margin | -422.32% | -204.17% |
| EBITD margin | - | -13.39% |
| Return on average assets | -88.78% | -52.98% |
| Return on average equity | - | - |
| Employees | 79 |
No comments:
Post a Comment